neomycin sulfate + framycetin sulfate

This is a combination antibiotic product containing neomycin sulfate and framycetin sulfate, developed and manufactured by Sichuan Long March Pharmaceutical. Both active ingredients are aminoglycoside antibiotics that exert their bactericidal effects by binding to the bacterial 30S ribosomal subunit. This binding inhibits protein synthesis and induces mRNA misreading, which leads to the production of nonfunctional proteins and subsequent bacterial cell death. The product is approved for the treatment of bacterial infections and is commonly used in topical or localized applications to target a broad spectrum of gram-positive and gram-negative organisms.

Other names

neomycin sulfate and framycetin sulfate